The implications of acute rejection and reduced allograft function on health care expenditures in contemporary US kidney transplantation

Transplantation

Volumn 94, Issue 3, 2012, Pages 241-249

  Gheorghian, Adrian ^a   Schnitzler, Mark A ^a   Axelrod, David A ^b   Kalsekar, Anupama ^c   L'Italien, Gilbert ^c,d   Lentine, Krista L ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute rejection; Glomerular filtration rate; Health care costs; Kidney transplantation; Medicare

Indexed keywords

ALEMTUZUMAB; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY; OKT 3; RITUXIMAB; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AFRICAN AMERICAN; AGE; ARTICLE; CYTOMEGALOVIRUS INFECTION; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; DIALYSIS; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; HEALTH CARE COST; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; UNITED STATES;

ADULT; AGED; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HEALTH CARE COSTS; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MEDICARE; MIDDLE AGED; REGRESSION ANALYSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; UNITED STATES;

EID: 84864681532     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318255f839     Document Type: Article

References (20)

1. Schnitzler MA, Whiting JF, Brennan DC, et al. The expanded criteria donor dilemmain cadaveric renal transplantation. Transplantation 2003; 75: 1940.
2. Nankivell BJ, Alexander SI. Rejection of the kidney allograft. N Engl J Med 2010; 363: 1451.
3. Stegall MD, Gloor JM. Deciphering antibody-mediated rejection: new insights into mechanisms and treatment. Curr Opin Organ Transplant 2010; 15: 8.
4. Englesbe MJ, Ads Y, Cohn JA, et al. The effects of donor and recipient practices on transplant center finances. Am J Transplant 2008; 8: 586.
5. Englesbe MJ, Dimick JB, Fan Z, et al. Case mix, quality and high-cost kidney transplant patients. Am J Transplant 2009; 9: 1108.
6. Machnicki G, Lentine KL, Salvalaggio PR, et al. Three-year posttransplant Medicare payments in kidney transplant recipients: associations with pre-transplant comorbidities. Saudi J Kidney Dis Transpl 2010; 22: 24.
7. Buchanan PM, Lentine KL, Burroughs TE, et al. Association of lower costs of pulsatile machine perfusion in renal transplantation from expanded criteria donors. Am J Transplant 2008; 8: 2391.
8. Miller JT, Collins CD, Stuckey LJ, et al. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression. Pharmacotherapy 2009; 29: 1166.
9. Kaufman DB, Leventhal JR, Axelrod D, et al. Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab inductionVlong-term results. Am J Transplant 2005; 5: 2539.
10. Hanaway MJ, Woodle ES, Mulgaonkar S, et al. Alemtuzumab induction in renal transplantation. N Engl J Med 2011; 364(20): 1909.
11. Pinsky BW, Takemoto SK, Lentine KL, et al. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 2009; 9: 2597.
12. Schnitzler MA, Lowell JA, Hardinger KL, et al. The association of cytomegalovirus sero-pairing with outcomes and costs following cadaveric renal transplantation prior to the introduction of oral ganciclovir CMV prophylaxis. Am J Transplant 2003; 3: 445.
13. Woodward RS, Schnitzler MA, Baty J, et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 2003; 3: 590.
14. Schnitzler MA, Johnston K, Axelrod D, et al. Associations of renal function at 1-year after kidney transplantation with subsequent return to dialysis, mortality, and healthcare costs. Transplantation 2011; 91: 1347.
15. Gheorghian A, Schnitzler MA, Axelrod DA, et al. The implications of acute rejection and reduced allograft function on health care expenditures in contemporary US kidney transplantation. Transplantation 2012; 94: 241. In press.
16. United States RenalData System. Researcher'sGuide to the United States Renal Data System Database, 2010. Available at: http://www.usrds.org/2010/rg/fb/ index.html. Accessed July 7, 2011.
17. UNOS Policy 3.5.1 Definition of Expanded Criteria Donor and Standard Donor.
18. Bureau of Labor Statistics. Consumer Price Index, US Average Medical Care. Available at: http://www.bls.gov/cpi/. Accessed July 7, 2011.
19. Levey AS, Greene T, Kusek JW, et al. A simplified equation to prediction glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: 155A.
20. Poggio ED, Wang X, Weinstein DM, et al. Assessing glomerular filtration rate by estimation equations in kidney transplant recipients. Am J Transplant 2006; 6: 100.